Precision BioSciences Inc (DTIL)
9.72
-0.10
(-1.02%)
USD |
NASDAQ |
Apr 25, 16:00
9.50
-0.22
(-2.26%)
After-Hours: 05:52
Precision BioSciences Revenue (TTM): 48.73M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 48.73M |
| September 30, 2023 | 52.29M |
| June 30, 2023 | 46.53M |
| March 31, 2023 | 30.56M |
| December 31, 2022 | 25.10M |
| September 30, 2022 | 20.84M |
| June 30, 2022 | 37.51M |
| March 31, 2022 | 102.50M |
| December 31, 2021 | 115.53M |
| September 30, 2021 | 118.04M |
| June 30, 2021 | 101.36M |
| Date | Value |
|---|---|
| March 31, 2021 | 33.64M |
| December 31, 2020 | 24.28M |
| September 30, 2020 | 21.96M |
| June 30, 2020 | 19.46M |
| March 31, 2020 | 23.77M |
| December 31, 2019 | 22.24M |
| September 30, 2019 | 20.66M |
| June 30, 2019 | 18.33M |
| March 31, 2019 | 14.82M |
| December 31, 2018 | 10.88M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
18.33M
Minimum
Jun 2019
118.04M
Maximum
Sep 2021
46.49M
Average
30.56M
Median
Mar 2023
Revenue (TTM) Benchmarks
| Altimmune Inc | 0.426M |
| BioVie Inc | -- |
| Adial Pharmaceuticals Inc | -- |
| Gritstone Bio Inc | 1.332M |
| Humacyte Inc | -- |